Therapeutic significance of D3 dissection for low rectal cancer: a comparison of dissections between the lateral pelvic lymph nodes and the lymph nodes along the root of the inferior mesenteric artery in a multicenter retrospective cohort study
- 3 February 2021
- journal article
- research article
- Published by Springer Science and Business Media LLC in International Journal of Colorectal Disease
- Vol. 36 (6), 1263-1270
- https://doi.org/10.1007/s00384-021-03858-1
Abstract
Purpose D3 dissection is the standard treatment modality for locally advanced low rectal cancer in Japan. The benefit of lateral pelvic lymph node (LPLN) dissection (LPLND) and lymph nodes along the root of inferior mesenteric artery (253 LN) dissection (253 LND) for low rectal cancer has often been studied separately, and few studies have investigated their benefit in the same cohort. This study aimed to clarify the therapeutic significance of dissection of the LPLN in comparison to that of dissection of the 253 LN for low rectal cancer. Methods We retrospectively evaluated 3508 patients with treatment-naïve stage I–III low rectal cancer who underwent mesorectal excision between 1997 and 2012. They were identified from the Japanese Study Group for Postoperative Follow-Up of Colorectal Cancer database. The rates of metastasis, survival, and therapeutic value index (5-year overall survival (OS) rate multiplied by metastatic rate for lymph node metastasis) were compared between LPLN and 253 LN. Results The rates of LPLN metastasis and 253 LN metastasis were 17.9% and 1.5%, respectively. The 5-year OS was significantly different between patients with and without LPLN metastasis (55.0% vs 85.5%, P < 0.0001) and between patients with and without 253 LN metastasis (36.2% vs 83.3%, P < 0.0001). The therapeutic value indexes of LPLN and 253 LN were 9.85 and 0.54, respectively. Conclusions LPLND may have more therapeutic value than 253 LND for patients with treatment-naïve low rectal cancer, although both the patients with LPLN metastasis and those with 253 LN metastasis remained to have poor prognosis.Keywords
Funding Information
- Grants-in-Aid for Scientific Research (C: grant number; 18K07194, C: grant number; 19K09114, C: grant number; 19K09115, C: grant number; 20K09051)
This publication has 34 references indexed in Scilit:
- Results of a Japanese Nationwide Multi-Institutional Study on Lateral Pelvic Lymph Node Metastasis in Low Rectal CancerAnnals of Surgery, 2012
- A Comparison Between the Treatment of Low Rectal Cancer in Japan and the Netherlands, Focusing on the Patterns of Local RecurrenceAnnals of Surgery, 2009
- Potential Prognostic Benefit of Lateral Pelvic Node Dissection for Rectal Cancer Located Below the Peritoneal ReflectionAnnals of Surgery, 2007
- Indication and Benefit of Pelvic Sidewall Dissection for Rectal CancerDiseases of the Colon & Rectum, 2006
- Survival benefit of high ligation of the inferior mesenteric artery in sigmoid colon or rectal cancer surgeryBritish Journal of Surgery, 2006
- Incidence and prognostic significance of lateral lymph node metastasis in patients with advanced low rectal cancerBritish Journal of Surgery, 2005
- New method to evaluate the therapeutic value of lymph node dissection for gastric cancerBritish Journal of Surgery, 1995
- Significance of lateral node dissection for advanced rectal carcinoma at or below the peritoneal reflectionDiseases of the Colon & Rectum, 1989
- THE LYMPHATIC AND VENOUS SPREAD OF CARCINOMA OF THE RECTUMAnnals of Surgery, 1942
- LYMPHATIC SPREAD OF CARCINOMA OF THE RECTUMAnnals of Surgery, 1938